Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • TEL vs MRNA✓SelectedUSD · MRNATEL vs MRNA performance historyLatest closeAs of-4.97%11/20
Stock and ETF performance explorer

TEL vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+59.2%
MRNA return
+153.9%
Excess return
-94.8%
Maximum drawdown
-22.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-5.0%-2.2%-2.8%-4.9%
7D-7.2%-12.7%+5.5%-6.7%
30D-6.2%-20.7%+14.4%-5.5%
3M+0.5%+46.3%-45.8%-1.2%
6M+0.4%+305.2%-304.8%-11.6%
YTD-10.8%+561.2%-572.1%-28.1%
1Y-5.4%+772.1%-777.5%-27.3%
3Y+59.2%+147.0%-87.8%+30.5%
All+59.2%+153.9%-94.8%+30.5%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling